Literature DB >> 17873685

Suicides by violent means in individuals taking SSRIs and other antidepressants: a postmortem study in Sweden, 1992-2004.

Seena Fazel1, Martin Grann, Johan Ahlner, Guy Goodwin.   

Abstract

A number of reports have linked consumption of selective serotonin reuptake inhibitors (SSRIs) with suicide by violent methods. We aimed to determine whether suicides with postmortem evidence of SSRI consumption are more likely to have used violent methods compared with suicides with no detectable antidepressants. Blood samples from all suicides in Sweden during 1992-2004 were examined. Suicides were classified into those who died by violence and nonviolent (self-poisoning) methods using information from police records and autopsy. In addition, we investigated proportions of violent suicide in individuals who died with detectable levels of tricyclic and other antidepressants. The sample consisted of 14,691 suicides. Of the 1958 suicides with detectable levels of SSRIs, 1247 were by violent means (63.7%) compared with 7835 of 11,045 suicides (70.9%) in antidepressant-free group (chi2(1) = 7.6; P < 0.01). [corrected] When subdivided by gender and age-bands, we found specific groups with significantly lower proportions of violent suicides compared with the antidepressants-free group, including men aged 15-24 years.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17873685     DOI: 10.1097/jcp.0b013e31814ce3ef

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  9 in total

1.  An intercalation mechanism as a mode of action exerted by psychotropic drugs: results of altered phospholipid substrate availabilities in membranes?

Authors:  Ramadhan Oruch; Anders Lund; Ian F Pryme; Holm Holmsen
Journal:  J Chem Biol       Date:  2010-01-27

2.  Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data.

Authors:  Sebastian Schneeweiss; Amanda R Patrick; Daniel H Solomon; Jyotsna Mehta; Colin Dormuth; Matthew Miller; Jennifer C Lee; Philip S Wang
Journal:  Arch Gen Psychiatry       Date:  2010-05

3.  Toxicological findings in suicides - frequency of antidepressant and antipsychotic substances.

Authors:  Maximilian Methling; Franziska Krumbiegel; Sven Hartwig; Maria K Parr; Michael Tsokos
Journal:  Forensic Sci Med Pathol       Date:  2018-11-05       Impact factor: 2.007

Review 4.  Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.

Authors:  Hans-Jürgen Möller; David S Baldwin; Guy Goodwin; Siegfried Kasper; Ahmed Okasha; Dan J Stein; Rajiv Tandon; Marcio Versiani
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-08       Impact factor: 5.270

5.  Selective serotonin re-uptake inhibitors and the risk of violent suicide: a nationwide postmortem study.

Authors:  Jonas Forsman; Thomas Masterman; Johan Ahlner; Göran Isacsson; Anna Karin Hedström
Journal:  Eur J Clin Pharmacol       Date:  2018-11-03       Impact factor: 2.953

6.  Economic conditions and suicide rates in New York City.

Authors:  Arijit Nandi; Marta R Prescott; Magdalena Cerdá; David Vlahov; Kenneth J Tardiff; Sandro Galea
Journal:  Am J Epidemiol       Date:  2012-02-22       Impact factor: 4.897

7.  Premature Death Among Primary Care Patients With a History of Self-Harm.

Authors:  Matthew J Carr; Darren M Ashcroft; Evangelos Kontopantelis; David While; Yvonne Awenat; Jayne Cooper; Carolyn Chew-Graham; Nav Kapur; Roger T Webb
Journal:  Ann Fam Med       Date:  2017-05       Impact factor: 5.166

Review 8.  The concept of violent suicide, its underlying trait and neurobiology: A critical perspective.

Authors:  Birgit Ludwig; Yogesh Dwivedi
Journal:  Eur Neuropsychopharmacol       Date:  2017-12-15       Impact factor: 4.600

Review 9.  Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies.

Authors:  Corrado Barbui; Eleonora Esposito; Andrea Cipriani
Journal:  CMAJ       Date:  2009-02-03       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.